title: Liver damage during interferon therapy for chronic myeloid leukaemia.
authors.forename: P
authors.initials: P
authors.lastname: Philippe
authors.forename: J
authors.initials: J
authors.lastname: Fialip
authors.forename: B
authors.initials: B
authors.lastname: Souweine
authors.forename: O
authors.initials: O
authors.lastname: Aumaitre
authors.forename: J C
authors.initials: JC
authors.lastname: Marcheix
authors.forename: J
authors.initials: J
authors.lastname: Lavarenne
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008107:Liver Diseases / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins